| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0757994A1 Tcf mutant |
| 02/12/1997 | EP0757993A1 Preventive for circulatory diseases |
| 02/12/1997 | EP0757722A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO) |
| 02/12/1997 | EP0757721A1 Regulatory element conferring tapetum specificity |
| 02/12/1997 | EP0757720A1 Trimerising polypeptides, their manufacture and use |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | EP0757697A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection |
| 02/12/1997 | EP0757696A1 Human sperm diagnostic |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0757556A1 $i(BORRELIA BURGDORFERI) BACTERIN |
| 02/12/1997 | EP0564588B1 Hexapeptide anaphylatoxin-receptor ligands |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | EP0440777B1 Brain derived neurotrophic factor |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142832A CS-1 peptidomimetics, compositions and methods of using the same |
| 02/12/1997 | CN1142829A Compounds and methods for site-directed mutations in eukaryotic cells |
| 02/12/1997 | CN1142774A Vibrio cholerae 01(CVD111) and Non-01(CVD112 and CVD112RM) serogroup vaccine strains and methods of making same |
| 02/12/1997 | CN1142771A Lyophilized stem cell factor formulations |
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/12/1997 | CN1142502A Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli |
| 02/12/1997 | CA2183012A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/11/1997 | USRE35450 Immunosuppressants, antiinflammatory agents |
| 02/11/1997 | US5602322 Constitutitive triple response gene and mutations |
| 02/11/1997 | US5602309 For study of neurodegenerative disorders, i.e. parkinson's and alzheimer's diseases |
| 02/11/1997 | US5602307 Non-human animal having predefined allele of a cellular adhesion gene |
| 02/11/1997 | US5602306 Transgenic pig expressing human hemoglobin |
| 02/11/1997 | US5602301 Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
| 02/11/1997 | US5602299 Express human neurofilament subunit gene, exhibit brain neurofibrillary tangles and pick-like bodies |
| 02/11/1997 | US5602243 For amplification of a deleted in colorectal cancer gene by polymerase chain reaction |
| 02/11/1997 | US5602234 Stable antibody solution and method for preparing same |
| 02/11/1997 | US5602233 Activation and deactivation |
| 02/11/1997 | US5602232 Reacting interferon with supersaturated solution of metal acetate |
| 02/11/1997 | US5602231 Process for making peptides |
| 02/11/1997 | US5602230 Peptide inhibitors of selectin binding |
| 02/11/1997 | US5602229 Pentapeptide antibiotics |
| 02/11/1997 | US5602098 Anticancer agent |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602034 Genetic engineering |
| 02/11/1997 | US5602033 Coccidiosis vaccine |
| 02/11/1997 | US5602032 Bacillus thuringiensis mutants which produce high yields of crystal delta-endotoxin |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602019 Genetic engineering |
| 02/11/1997 | US5602018 Having uniform low glycosylation, improved thermal stability |
| 02/11/1997 | US5602015 Autoantibodies which enhance the rate of a chemical reaction |
| 02/11/1997 | US5602014 Genetic engineering; hydrolyzing acrylonitrile with transformed microorganism of genus rhodococcus to produce acrylic acid |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602009 Expressing in recombinant host cell transfected dna encoding trans-repressing chimeric receptors comprising dna-binding domain linked to specified sequence of v-erba protein |
| 02/11/1997 | US5602008 Genetic engineering |
| 02/11/1997 | US5602007 Recombinant DNA molecules |
| 02/11/1997 | US5602006 Heteropolymeric protein production methods |
| 02/11/1997 | US5602005 Antigen remains associated with primate sperm after acrosome reaction |
| 02/11/1997 | US5601990 Methods of diagnosing colorectal tumors and metastasis thereof |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601974 Method of detecting viral infection in vaccinated animals |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601830 Staphylococcus aureus enterotoxin H and methods of use |
| 02/11/1997 | US5601828 CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601826 A linear tetanus-toxin-specific epitope |
| 02/11/1997 | US5601825 Therapeutic conjugates of toxins and drugs |
| 02/11/1997 | US5601823 Avian antitoxins to clostridium difficle toxin A |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601820 Amino acid sequence of human neurotropic factor |
| 02/11/1997 | US5601816 Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production of same |
| 02/11/1997 | US5601799 Glycoprotein has affinity to macrophages, useage as drug delivery |
| 02/11/1997 | CA1338900C Escherichia coli plasmid vector with lipoprotein promoter and modified shine-dalgarno sequence |
| 02/06/1997 | WO1997004317A1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004133A1 Analysis of alpha integrins for the diagnosis of diabetic nephropathy |
| 02/06/1997 | WO1997004124A1 Methods of screening compounds for their pharmacological relevance based on downregulation of recombinant receptors |
| 02/06/1997 | WO1997004123A1 Collagen compound production in plants |
| 02/06/1997 | WO1997004122A1 Production of secreted foreign polypeptides in plant cell culture |
| 02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | WO1997004117A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | WO1997004115A2 Method for producing haemin proteins using plant cells, resulting proteins and products containing same |
| 02/06/1997 | WO1997004114A2 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
| 02/06/1997 | WO1997004110A1 Methods for increasing protein expression |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004098A2 MODIFIED HUMAN CHORIONIC (β-hCG) PROTEINS AND THEIR MEDICAL USE |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997004094A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004091A1 Novel receptor ligands and genetic sequences encoding same |
| 02/06/1997 | WO1997004090A1 SEQUENCE AND EXPRESSION OF Sox-18 |
| 02/06/1997 | WO1997004089A2 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | WO1997004088A1 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997004076A1 Synthetic hpv11 virus-like particles |